Peter A Abaci, MD
Interventional Pain Management · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 19
- 5 carriers
- Office
- 1
- Since medical school
- 31 years
- University of Southern California Keck School of Medicine, 1995
Offices
1 location · Integrated Pain Management Medical Group Inc · 42 clinicians in this group
Plans that list them
19 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Abaci’s office at (925) 482-8151 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
19 of 19 plans
| Aetna Medicare Eagle (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G76565 · Current
Licensed to practise in California · since 1993 · expires 2027-04-30 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Silicon Valley Surgery Center, LPAmbulatory Surgery Center · Campbell, CA1.15% owner since 1999 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2024-09-16
- Silicon Valley Surgery Center, LP - BascomAmbulatory Surgery Center · Campbell, CA1.15% owner since 1999 · accredited by AAAHCAccreditation RenewedNo inspections published
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Anesthesiology - Anesthesiology
- American Board of Pain Medicine - Pain Medicine
Original Medicare doctor bills
$149,369
Medicare paid this office $149,369 for 139 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 97 | $54,204 | $242 |
| Return visit (30+ min) | 108 | $49,121 | $106 |
| Telephone medical discussion with physician, 11-20 minutes | 50 | $8,904 | $75 |
| Short return visit (20+ min) | 52 | $8,172 | $77 |
| Telephone medical discussion with physician, 21-30 minutes | 28 | $3,820 | $98 |
See all 9 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 97 | $54,204 | $242 |
| Return visit (30+ min) | 108 | $49,121 | $106 |
| Telephone medical discussion with physician, 11-20 minutes | 50 | $8,904 | $75 |
| Short return visit (20+ min) | 52 | $8,172 | $77 |
| Telephone medical discussion with physician, 21-30 minutes | 28 | $3,820 | $98 |
| Acupuncture, each additional 15 minutes | 19 | $3,245 | $24 |
| Acupuncture, initial 15 minutes | 15 | $2,489 | $31 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 14 | $2,276 | $120 |
| Application of low energy heat | 19 | $701 | $5 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 27 | 15 | 17 | 24 | 20 | 19 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | – | – | – | 17 | – | – |
| Injection of substance into lower spine canal using imaging guidance | 16 | – | – | – | – | – |
| Injection of substance into middle or upper spine canal using imaging guidance | – | 15 | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
139 Original Medicare patients in 2024. Average age 70 · Under 65 27% · 85 and older 9% · Women 63% · Also on Medicaid 20% · Health risk score 1.18. At or below the middle of the specialty; the typical interventional pain management clinician is at 1.37.
Conditions among them: High blood pressure 63% · Depression 32% · Chronic kidney disease 25% · Diabetes 24% · Coronary heart disease 19% · Heart failure 15% · Atrial fibrillation 12% · Cancer 9% · COPD 9%.
The office billed $1,146,318, Medicare allowed $182,781 and paid $149,369; for 1,695 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 139 | 1,695 | 70 | 1.18 | $1,146,318 | $149,369 |
| 2023 | 170 | 2,347 | 70 | 1.21 | $421,498 | $197,386 |
| 2022 | 238 | 4,652 | 71 | 1.20 | $493,137 | $360,931 |
| 2021 | 255 | 4,664 | 70 | 1.09 | $485,802 | $369,967 |
| 2020 | 272 | 4,695 | 69 | 1.17 | $429,674 | $329,879 |
| 2019 | 235 | 1,822 | 69 | 1.20 | $220,716 | $156,360 |
| 2018 | 93 | 514 | 72 | 1.19 | $78,393 | $51,496 |
| 2017 | 80 | 327 | 72 | 1.12 | $74,543 | $24,511 |
| 2016 | 97 | 330 | 71 | 1.15 | $86,850 | $22,611 |
| 2015 | 101 | 619 | 71 | 1.25 | $108,835 | $30,919 |
| 2014 | 107 | 442 | 70 | 1.10 | $116,745 | $35,733 |
| 2013 | 141 | 365 | 70 | 1.11 | $60,507 | $26,906 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 137 | $83,596 | $108 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 115 | $57,367 | $241 |
| Evaluation of psychological test, first hour | 63 | $14,055 | $88 |
| Short return visit (20+ min) | 70 | $10,021 | $74 |
| Acupuncture, initial 15 minutes | 24 | $4,533 | $33 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 78 | $3,856 | $28 |
| Acupuncture, each additional 15 minutes | 25 | $3,333 | $25 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 14 | $2,326 | $116 |
| Acupuncture with electrical stimulation, initial 15 minutes | 14 | $1,079 | $40 |
| Application of low energy heat | 25 | $1,036 | $6 |
2022: 24 services
| Return visit (30+ min) | 165 | $113,276 | $111 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 140 | $71,512 | $242 |
| Evaluation of psychological test, first hour | 148 | $70,334 | $101 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 179 | $26,482 | $34 |
| Short return visit (20+ min) | 91 | $17,558 | $75 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 139 | $13,807 | $53 |
| Acupuncture, initial 15 minutes | 32 | $5,168 | $36 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 18 | $4,799 | $21 |
| Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | 16 | $3,842 | $27 |
| Acupuncture, each additional 15 minutes | 32 | $3,229 | $26 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 20 | $2,945 | $123 |
| Extended patient service without direct patient contact, first hour | 17 | $1,959 | $98 |
| Acupuncture with electrical stimulation, initial 15 minutes | 14 | $1,914 | $43 |
| Psychiatric diagnostic evaluation | 11 | $1,489 | $135 |
| New patient visit (45+ min) | 13 | $1,402 | $108 |
| New patient visit (30+ min) | 12 | $1,081 | $90 |
| Application of low energy heat | 32 | $1,030 | $6 |
| Evaluation of psychological test, each additional hour | 12 | $976 | $75 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 16 | $936 | $59 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 13 | $886 | $52 |
| Administration of psychological or neuropsychological test, first 30 minutes | 12 | $479 | $40 |
| Administration of psychological or neuropsychological test, each additional 30 minutes | 12 | $479 | $37 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $472 | $10 |
| Whole body composition tissue and fluid measurements with interpretation and report | 42 | $425 | $9 |
2021: 16 services
| Return visit (30+ min) | 169 | $104,674 | $117 |
| Evaluation of psychological test, first hour | 186 | $68,341 | $102 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 149 | $65,967 | $245 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 202 | $35,093 | $37 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 205 | $29,824 | $37 |
| Short return visit (20+ min) | 93 | $20,807 | $81 |
| Psychotherapy, 1 hour | 12 | $12,159 | $129 |
| New patient visit (45+ min) | 25 | $3,953 | $158 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 11 | $3,173 | $23 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 14 | $2,305 | $136 |
| Acupuncture with electrical stimulation, each additional 15 minutes | 11 | $1,769 | $32 |
| Acupuncture with electrical stimulation, initial 15 minutes | 11 | $1,749 | $39 |
| Acupuncture, initial 15 minutes | 11 | $1,248 | $33 |
| Acupuncture, each additional 15 minutes | 11 | $1,199 | $24 |
| Whole body composition tissue and fluid measurements with interpretation and report | 60 | $584 | $9 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $334 | $12 |
2020: 16 services
| Evaluation of psychological test, first hour | 198 | $77,540 | $104 |
| Return visit (30+ min) | 133 | $72,627 | $95 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 121 | $50,115 | $243 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 252 | $47,807 | $38 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 177 | $33,849 | $38 |
| Short return visit (20+ min) | 74 | $10,547 | $68 |
| Psychotherapy, 1 hour | 12 | $7,162 | $119 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 18 | $3,586 | $22 |
| New patient visit (60+ min) | 16 | $3,143 | $196 |
| Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | 21 | $2,976 | $29 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 11 | $2,095 | $140 |
| Psychiatric diagnostic evaluation | 14 | $1,790 | $128 |
| Injection of substance into middle or upper spine canal using imaging guidance | 11 | $1,532 | $102 |
| Re-evaluation for physical therapy, typically 20 minutes | 12 | $1,081 | $57 |
| Evaluation for physical therapy, typically 45 minutes | 11 | $944 | $86 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $329 | $11 |
2019: 14 services
| Return visit (30+ min) | 179 | $41,189 | $89 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 127 | $40,192 | $239 |
| Evaluation of psychological test, first hour | 117 | $26,851 | $99 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 183 | $16,422 | $38 |
| Short return visit (20+ min) | 49 | $5,565 | $61 |
| Psychotherapy, 1 hour | 16 | $3,575 | $105 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 19 | $3,567 | $132 |
| Psychiatric diagnostic evaluation | 13 | $1,531 | $118 |
| New patient visit (45+ min) | 13 | $1,463 | $113 |
| Injection of substance into lower spine canal using imaging guidance | 14 | $1,448 | $90 |
| Evaluation of psychological test, each additional hour | 12 | $908 | $76 |
| Administration of psychological or neuropsychological test, first 30 minutes | 14 | $599 | $43 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 35 | $529 | $10 |
| Administration of psychological or neuropsychological test, each additional 30 minutes | 13 | $517 | $40 |
2018: 8 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 48 | $17,907 | $242 |
| Return visit (30+ min) | 56 | $14,113 | $93 |
| Short return visit (20+ min) | 29 | $2,904 | $59 |
| Long return visit (40+ min) | 14 | $2,549 | $127 |
| New patient visit (45+ min) | 15 | $2,245 | $150 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 14 | $2,135 | $133 |
| New patient visit (60+ min) | 13 | $1,948 | $150 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 29 | $485 | $11 |
2017: 6 services
| Short return visit (20+ min) | 53 | $7,616 | $67 |
| Return visit (30+ min) | 28 | $4,386 | $104 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 11 | $2,459 | $129 |
| Injection of substance into lower spine canal using imaging guidance | 11 | $1,486 | $93 |
| New patient visit (30+ min) | 12 | $1,164 | $97 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 27 | $546 | $11 |
2016: 6 services
| Short return visit (20+ min) | 67 | $9,368 | $63 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 12 | $1,923 | $96 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 31 | $1,892 | $36 |
| Return visit (30+ min) | 13 | $1,806 | $95 |
| New patient visit (30+ min) | 18 | $1,794 | $100 |
| Injections of substances into lower or sacral spine | 11 | $1,158 | $72 |
2015: 5 services
| Short return visit (20+ min) | 68 | $11,647 | $59 |
| New patient visit (30+ min) | 37 | $3,489 | $94 |
| Injections of substances into lower or sacral spine | 17 | $1,682 | $76 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 26 | $1,441 | $37 |
| Return visit (30+ min) | 13 | $1,179 | $74 |
2014: 5 services
| Short return visit (20+ min) | 68 | $11,491 | $61 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 16 | $2,370 | $103 |
| Return visit (30+ min) | 17 | $2,337 | $90 |
| New patient visit (45+ min) | 16 | $2,241 | $140 |
| New patient visit (30+ min) | 18 | $1,573 | $87 |
2013: 7 services
| Short return visit (20+ min) | 65 | $7,906 | $59 |
| Return visit (30+ min) | 57 | $6,193 | $94 |
| New patient visit (30+ min) | 22 | $2,211 | $100 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 13 | $2,086 | $110 |
| New patient visit (45+ min) | 11 | $1,602 | $146 |
| Injections of substances into lower or sacral spine | 14 | $1,225 | $82 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $469 | $17 |
Medicaid work
$150 in 2024
Medicaid paid $150 for 13 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $150 |
| 2024 | 13 | 1 | 13 | $150 |
| 2023 | 130 | 1 | 16 | $1,013 |
| 2022 | 281 | 3 | 21 | $1,664 |
| 2021 | 544 | 3 | 32 | $14,903 |
| 2020 | 722 | 2 | 71 | $25,657 |
| 2019 | 126 | 1 | 29 | $8,001 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 130 | $1,013 |
2022
| Return visit (30+ min) | 188 | $1,244 |
| Psychological or neuropsychological test administration and scoring by technician, two or more tests, any method; first 30 minutes | 52 | $375 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 41 | $45 |
2021
| Return visit (30+ min) | 238 | $10,295 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 249 | $3,907 |
| Psychological or neuropsychological test administration and scoring by technician, two or more tests, any method; first 30 minutes | 57 | $702 |
2020
| Return visit (30+ min) | 295 | $15,643 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 427 | $10,014 |
2019
| Return visit (30+ min) | 126 | $8,001 |
Drugs they prescribed that Part D paid
$4,787
Pharmacies billed $4,787 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 25% of their Part D prescriptions (30 of 120) in 2024. At or below the middle of the specialty; the typical interventional pain management clinician is at 49%.
113 generic and fewer than 11 brand-name prescriptions · $4,787 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine | 11 | $686 | $62 |
| Hydrocodone-Acetaminophen | 15 | $346 | $23 |
| Gabapentin | 12 | $97 | $8 |
Year by year
| 2024 | 120 | 39 | 25% (30) | None | $4,787 |
| 2023 | 274 | 75 | 23% (64) | 8% | $13,082 |
| 2022 | 482 | 99 | 19% (90) | 11% | $48,375 |
| 2021 | 321 | 104 | 18% (57) | 12% | $35,896 |
| 2020 | 398 | 113 | 13% (52) | None | $23,294 |
| 2019 | 842 | 175 | 8% (64) | 9% | $68,986 |
| 2018 | 443 | 69 | 20% (90) | 8% | $30,268 |
| 2017 | 367 | 66 | 39% (142) | 7% | $18,517 |
| 2016 | 394 | 65 | 52% (204) | 9% | $25,464 |
| 2015 | 413 | 98 | 45% (184) | 13% | $32,111 |
| 2014 | 291 | 93 | 53% (153) | 14% | $24,701 |
| 2013 | 275 | 69 | 42% (115) | 21% | $29,976 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Hydrocodone-Acetaminophen | 28 | $1,275 | $46 |
| Gabapentin | 43 | $985 | $23 |
| Celecoxib | 18 | $955 | $53 |
| Tizanidine | 21 | $784 | $37 |
| Buprenorphine | 16 | $519 | $32 |
| Cyclobenzaprine | 11 | $75 | $7 |
| Hydromorphone | 11 | $74 | $7 |
2022: 13 drugs
| Suboxone | 12 | $13,842 | $1,154 |
| Lidocaine | 13 | $2,139 | $165 |
| Duloxetine | 22 | $1,806 | $82 |
| Gabapentin | 81 | $1,666 | $21 |
| Tizanidine | 42 | $1,280 | $30 |
| Buprenorphine | 19 | $913 | $48 |
| Diclofenac | 12 | $824 | $69 |
| Nabumetone | 23 | $752 | $33 |
| Hydrocodone-Acetaminophen | 21 | $599 | $29 |
| Oxycodone-Acetaminophen | 15 | $458 | $31 |
| Pantoprazole | 16 | $318 | $20 |
| Cyclobenzaprine | 19 | $236 | $12 |
| Trazodone | 12 | $159 | $13 |
2021: 9 drugs
| Buprenorphine-Naloxone | 29 | $7,823 | $270 |
| Zubsolv | 16 | $7,800 | $487 |
| Buprenorphine | 42 | $2,551 | $61 |
| Hydrocodone-Acetaminophen | 19 | $812 | $43 |
| Gabapentin | 33 | $783 | $24 |
| Diclofenac | 16 | $497 | $31 |
| Tizanidine | 11 | $173 | $16 |
| Cyclobenzaprine | 12 | $132 | $11 |
| Tramadol | 11 | $63 | $6 |
2020: 13 drugs
| Buprenorphine | 45 | $5,909 | $131 |
| Buprenorphine-Naloxone | 12 | $3,951 | $329 |
| Hydrocodone-Acetaminophen | 25 | $1,181 | $47 |
| Gabapentin | 50 | $1,048 | $21 |
| Celecoxib | 12 | $613 | $51 |
| Pregabalin | 11 | $570 | $52 |
| Duloxetine | 13 | $492 | $38 |
| Diclofenac | 15 | $446 | $30 |
| Trazodone | 18 | $316 | $18 |
| Cyclobenzaprine | 29 | $264 | $9 |
| Ibuprofen | 14 | $102 | $7 |
| Tramadol | 19 | $100 | $5 |
| Omeprazole | 14 | $79 | $6 |
2019: 21 drugs
| Suboxone | 20 | $12,750 | $638 |
| Buprenorphine | 59 | $7,793 | $132 |
| Buprenorphine-Naloxone | 27 | $7,563 | $280 |
| Lyrica | 13 | $7,547 | $581 |
| Gabapentin | 150 | $4,436 | $30 |
| Diclofenac | 36 | $1,881 | $52 |
| Duloxetine | 29 | $1,769 | $61 |
| Celecoxib | 30 | $1,591 | $53 |
| Hydrocodone-Acetaminophen | 18 | $894 | $50 |
| Tizanidine | 30 | $707 | $24 |
| Trazodone | 36 | $580 | $16 |
| Ibuprofen | 47 | $434 | $9 |
| Nabumetone | 18 | $432 | $24 |
| Cyclobenzaprine | 49 | $381 | $8 |
| Baclofen | 18 | $378 | $21 |
| Rizatriptan | 14 | $338 | $24 |
| Omeprazole | 26 | $188 | $7 |
| Meloxicam | 25 | $179 | $7 |
| Escitalopram | 17 | $162 | $10 |
| Tramadol | 23 | $124 | $5 |
| Fluoxetine | 11 | $37 | $3 |
2018: 14 drugs
| Suboxone | 12 | $8,553 | $713 |
| Buprenorphine | 24 | $3,593 | $150 |
| Gabapentin | 74 | $2,394 | $32 |
| Celecoxib | 24 | $1,745 | $73 |
| Diclofenac | 15 | $1,109 | $74 |
| Oxycodone-Acetaminophen | 15 | $767 | $51 |
| Hydrocodone-Acetaminophen | 23 | $689 | $30 |
| Nabumetone | 21 | $512 | $24 |
| Duloxetine | 13 | $457 | $35 |
| Trazodone | 23 | $415 | $18 |
| Tizanidine | 17 | $262 | $15 |
| Tramadol | 32 | $201 | $6 |
| Cyclobenzaprine | 23 | $97 | $4 |
| Meloxicam | 12 | $79 | $7 |
2017: 9 drugs
| Celecoxib | 13 | $2,112 | $162 |
| Oxycodone-Acetaminophen | 25 | $1,242 | $50 |
| Gabapentin | 47 | $1,190 | $25 |
| Tramadol | 67 | $631 | $9 |
| Hydrocodone-Acetaminophen | 26 | $498 | $19 |
| Tizanidine | 15 | $327 | $22 |
| Trazodone | 19 | $251 | $13 |
| Nabumetone | 14 | $238 | $17 |
| Omeprazole | 21 | $186 | $9 |
2016: 7 drugs
| Oxycontin | 20 | $12,748 | $637 |
| Hydrocodone-Acetaminophen | 60 | $2,625 | $44 |
| Oxycodone-Acetaminophen | 32 | $1,378 | $43 |
| Gabapentin | 52 | $1,302 | $25 |
| Oxycodone | 13 | $577 | $44 |
| Tramadol | 61 | $463 | $8 |
| Trazodone | 16 | $140 | $9 |
2015: 10 drugs
| Oxycontin | 25 | $12,478 | $499 |
| Celecoxib | 18 | $3,034 | $169 |
| Oxycodone-Acetaminophen | 35 | $2,311 | $66 |
| Hydrocodone-Acetaminophen | 48 | $1,786 | $37 |
| Oxycodone | 14 | $828 | $59 |
| Gabapentin | 36 | $627 | $17 |
| Trazodone | 25 | $233 | $9 |
| Tramadol | 24 | $169 | $7 |
| Carisoprodol | 13 | $126 | $10 |
| Acetaminophen-Codeine | 15 | $94 | $6 |
2014: 7 drugs
| Hydrocodone-Acetaminophen | 62 | $2,032 | $33 |
| Oxycodone-Acetaminophen | 11 | $645 | $59 |
| Gabapentin | 17 | $445 | $26 |
| Oxycodone | 11 | $386 | $35 |
| Carisoprodol | 11 | $185 | $17 |
| Tramadol | 17 | $133 | $8 |
| Alprazolam | 12 | $109 | $9 |
2013: 6 drugs
| Oxycontin | 15 | $9,243 | $616 |
| Suboxone | 13 | $4,664 | $359 |
| Buprenorphine | 12 | $1,347 | $112 |
| Hydrocodone-Acetaminophen | 48 | $1,335 | $28 |
| Gabapentin | 19 | $592 | $31 |
| Tramadol | 19 | $203 | $11 |
Money from drug and device companies
$135 in 2025
| 2025 | 1 | 8 | None | $135 |
| 2024 | 1 | 8 | None | $244 |
| 2023 | 2 | 7 | None | $145 |
| 2022 | 2 | 4 | None | $76 |
| 2021 | 4 | 5 | None | $169 |
| 2019 | 1 | 1 | None | $17 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Electronic Waveform Lab | None | $135 | 8 payments
|
See all 8 published payments
| Electronic Waveform Lab | Meals · 2025-12-02 | None | $30 |
| Electronic Waveform Lab | Meals · 2025-12-01 | None | $34 |
| Electronic Waveform Lab | Meals · 2025-10-21 | None | $10 |
| Electronic Waveform Lab | Meals · 2025-07-17 | None | $7 |
| Electronic Waveform Lab | Meals · 2025-05-13 | None | $35 |
| Electronic Waveform Lab | Meals · 2025-03-18 | None | $5 |
| Electronic Waveform Lab | Meals · 2025-02-25 | None | $8 |
| Electronic Waveform Lab | Meals · 2025-01-21 | None | $6 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $244
| Electronic Waveform Lab | None | $244 | 8 payments
|
2023: $145
| Electronic Waveform Lab | None | $136 | 6 payments
|
| Saluda Medical Americas | Evoke Scs | $9 | 1 payment
|
2022: $76
| Abbvie | Botox | $42 | 2 payments
|
| Electronic Waveform Lab | None | $34 | 2 payments
|
2021: $169
| AbbVie | Ubrelvy | $61 | 2 payments
|
| Emergent BioSolutions | Narcan | $45 | 1 payment
|
| GRT US Holding | Qutenza | $45 | 1 payment
|
| Baudax Bio | Anjeso | $19 | 1 payment
|
2019: $17
| Zyla Life Sciences | Sprix | $17 | 1 payment
|
Professional record
- NPI
- 1447200761
- Licence
- CA G76565California G76565: Current · expires 2027-04-30
- Trained
- University of Southern California Keck School of Medicine, 1995 · 31 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208VP0014X (208VP0014X); Federal specialty code 207L00000X (207L00000X); Federal specialty code 207LP2900X (207LP2900X); Federal specialty code 208VP0000X (208VP0000X)
- Mailing address
- 15047 Los Gatos Blvd Ste 200, Los Gatos, CA, 95032
- NPI first listed
- 2006-05-10
- NPI last updated
- 2017-04-11
This is when the NPI record was last certified, not a medical board exam.